Hemostastic embolization in oncology

Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):807-21. doi: 10.1016/j.diii.2015.06.008. Epub 2015 Jul 15.

Abstract

Several mechanisms predispose to bleeding in neoplastic disease. This is all the more serious as it often occurs on a background of medically vulnerable patients and the magnitude of the bleed may lead to hemorrhagic shock or acute respiratory distress as a result of hemoptysis. It often carries a poor prognosis, even if the acute episode has been controlled, as bleeding due to rupture of a tumor often indicates an advanced stage of the disease, and also because tumor rupture carries a risk of metastatic spread including peritoneal carcinomatosis. The risk of recurrent bleeding is also not insignificant. In most cases, endovascular hemostatic embolization is the first line palliative treatment.

Keywords: Hemorrhage; Hemostatic embolization; Tumor rupture.

Publication types

  • Review

MeSH terms

  • Angiography
  • Embolization, Therapeutic / methods*
  • Hemoptysis / etiology
  • Hemoptysis / therapy
  • Hemorrhage / diagnosis
  • Hemorrhage / etiology*
  • Hemorrhage / therapy*
  • Humans
  • Neoplasm Staging
  • Neoplasms / blood supply*
  • Neoplasms / complications*
  • Neoplasms / pathology
  • Neoplastic Cells, Circulating
  • Neovascularization, Pathologic / complications
  • Neovascularization, Pathologic / therapy
  • Prognosis
  • Recurrence
  • Risk Factors
  • Rupture, Spontaneous
  • Shock, Hemorrhagic / etiology
  • Shock, Hemorrhagic / therapy
  • Tomography, X-Ray Computed